
Mimi Lee, MD, PhD, noted that broader use of genomic testing could allow pediatric care to move beyond symptom-based diagnoses toward individualized treatment strategies.

Mimi C. Lee, MD, PhD, Chief of Precision Genetic Medicine, GeneDx, San Francisco Bay Area.

Mimi Lee, MD, PhD, noted that broader use of genomic testing could allow pediatric care to move beyond symptom-based diagnoses toward individualized treatment strategies.

Mimi C. Lee, MD, PhD, outlines why genomic sequencing remains a powerful but carefully targeted tool in pediatric medicine today, as advancements continue.

GeneDx’s ExomeDx and GenomeDx tests, now FDA Breakthrough Designated, offer comprehensive genomic analysis to improve diagnosis of rare and serious diseases.

Published: December 15th 2025 | Updated:

Published: January 9th 2026 | Updated: